Live Breaking News & Updates on Junior Manager Public

Stay updated with breaking news from Junior manager public. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

Issuer: CureVac

/ Key word: Study

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK. ....

United States , Sarah Fakih , Myriam Mendila , Patrick Perez , Corporate Communications , Development In Collaboration , World Health Organization , Curevac Announces Dosing , First Participant , Seasonal Influenza , Chief Scientific Officer , Junior Manager Public , Vice President Corporate Communications ,

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development

Issuer: CureVac / Key word(s): Study28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK  Phase 2 study to assess updated formulations for im. ....

United States , Patrick Perez , Sarah Fakih , Myriam Mendila , Development In Collaboration , Curevac Corporate Services Gmb , Corporate Communications , World Health Organization , Curevac Inc , Exchange Commission , Distribution Services , Vac Announces Dosing , First Participant , Seasonal Influenza , Chief Scientific Officer , Junior Manager Public , Vice President Corporate Communications , Curevac Manufacturing Gmbh , Curevac Swiss , Curevac Corporate Services Gmbh , Curevac Belgium , Corporate News , Regulatory Announcements ,

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Issuer: CureVac

/ Key word: Quarter Results

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

23.05.2024 / 13:00. ....

United Kingdom , United States , Patrick Perez , Sarah Fakih , Pierre Kemula , Alexander Zehnder , Contract Manufacturing Organization , Rna Vaccine Program , Curevac Inc , Exchange Commission , Supreme Court , Drug Administration , German Federal Patent Court On , Curevac Corporate Services Gmb , Corporate Communications , Curevac Announces Financial Results , First Quarter , Provides Business , Acuitas Therapeutics , Fast Track , Chief Executive Officer , Chief Financial Officer , Broad Second Generation , Jointly Developed , Intellectual Property , German Federal Patent Court ,

EQS-News: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update | Company Announcement

Investegate announcements from EQS-News: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update ....

United Kingdom , United States , Sarah Fakih , Alexander Zehnder , Pierre Kemula , Patrick Perez , Exchange Commission , Contract Manufacturing Organization , Rna Vaccine Program , Curevac Inc , Curevac Corporate Services Gmb , Supreme Court , Corporate Communications , German Federal Patent Court On , Drug Administration , Curevac Announces Financial Results , First Quarter , Provides Business , Acuitas Therapeutics , Fast Track , Chief Executive Officer , Chief Financial Officer , Broad Second Generation , Jointly Developed , Intellectual Property , German Federal Patent Court ,

CureVac AG: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine ....

United States , United Kingdom , Patrick Perez , Alexander Zehnder , Sarah Fakih , Pierre Kemula , Rna Vaccine Program , Exchange Commission , Contract Manufacturing Organization , Corporate Communications , Curevac Inc , Curevac Corporate Services Gmb , Supreme Court , Drug Administration , German Federal Patent Court On , Acuitas Therapeutics , Fast Track , Chief Executive Officer , Chief Financial Officer , Broad Second Generation , Jointly Developed , Intellectual Property , German Federal Patent Court , First Quarter , Finance Income , Junior Manager Public ,